Experimental treatments are being considered to cope with the current Ebola outbreak in the Democratic Republic of Congo. An experimental vaccine is already being administered.

In France, considerations around experimental treatments are notably lead within the REACTing platform of Inserm, in collaboration with the research institutes grouped under the Alliance for Life Sciences and Health (Aviesan).